Singapore markets close in 1 hour 3 minutes
Straits Times Index
3,310.67 +21.25 (+0.65%) Nikkei
38,920.26 +534.53 (+1.39%) Hang Seng
19,340.87 +267.16 (+1.40%) FTSE 100
8,419.89 -25.91 (-0.31%) Bitcoin USD
66,163.45 +3,987.26 (+6.41%) CMC Crypto 200
1,378.49 -15.55 (-1.12%)
DYN May 2024 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:41PM EDT. Market open.
| Previous close | 4.3000 |
| Open | 4.1400 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 4.1400 - 4.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Simply Wall St.We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
GlobeNewswireDyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 - WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2024 and recent business highlights. “I am excited about
© 2024 Yahoo. All rights reserved.